DJIA 18,118.68 -44.31 -0.24%
NASDAQ 5,097.03 -9.57 -0.19%
S&P 500 2,120.41 -3.07 -0.14%
market minute promo

Eli Lilly & Co. (NYSE: LLY)

76.25 1.35 (1.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

LLY $76.25 1.80%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $74.80
Previous Close $74.90
Daily Range $74.74 - $76.35
52-Week Range $58.50 - $77.46
Market Cap $84.6B
P/E Ratio 36.54
Dividend (Yield) $2.00 (2.7%)
Ex-Dividend Date
Dividend Pay Date
05/14/15
06/10/15
Volume 2,876,773
Average Daily Volume 3,835,987
Current FY EPS $3.15

Sector

Healthcare

Industry

Drug Makers

Eli Lilly & Co. (LLY) Description

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Website: http://www.lilly.com/

News & Commentary Rss Feed

How Will Big Pharma Fight Back Against MannKind?

Afrezza, an inhaled insulin, is officially on the market, and threatens many big industry leaders. How will big pharma fight back against the inhaled insulin threat?

3 Drugs Stocks Nudging The Industry Higher

Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data

Lilly to Present New Clinical Data at 75th American Diabetes Association Scientific Sessions

Abbvie Inc. Dividend Stock Analysis

Eli Lilly & Company - ZER Reports

A Review Of Amgen's AMG 334

New Issue- Eli Lilly prices a triple tranche deal

Could Incoming Threats Sink MannKind Corporation?

Big Pharma suspected that MannKind's Afrezza would make its way to the market eventually. Now that its here, what does the industry have in its pipeline that could potentially slow adoption?

3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog

3 Stocks Poised to Grow in the Schizophrenia Market - Analyst Blog

See More LLY News...

LLY's Top Competitors

LLY $76.25 (1.80%)
Current stock: LLY
JNJ $101.17 (0.04%)
Current stock: JNJ
NVS $104.31 (0.75%)
Current stock: NVS
RHHBY $37.37 (1.30%)
Current stock: RHHBY